Similarly, Leroy et al. [28] found that serum ESM-1 concentration in patients with renal clear cell carcinoma can be used as an effective monitoring indicator for postoperative treatment and anti-angiogenic therapy in patients with renal clear cell carcinoma. The gene discussed is ESM1; the disease is clear cell renal carcinoma.